<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00993785</url>
  </required_header>
  <id_info>
    <org_study_id>CP-04</org_study_id>
    <nct_id>NCT00993785</nct_id>
  </id_info>
  <brief_title>CoStar Catheter System Evaluation</brief_title>
  <acronym>CONCISE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Conor Medsystems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Conor Medsystems</source>
  <brief_summary>
    <textblock>
      To evaluate product performance and safety of the Catheter Design for the treatment of a&#xD;
      single coronary lesion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    CoStar Stent IDE failed to meet primary endpoint&#xD;
  </why_stopped>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Symptomatic Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>OTW Catheter System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Costar Coronary Stent Delivery System</intervention_name>
    <arm_group_label>OTW Catheter System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is ≥18 years of age.&#xD;
&#xD;
          2. Eligible for percutaneous coronary intervention (PCI).&#xD;
&#xD;
          3. Documented stable or unstable angina pectoris (Canadian Cardiovascular Society&#xD;
             Classification [CCS] 1, 2, 3, or 4), documented ischemia, or documented silent&#xD;
             ischemia.&#xD;
&#xD;
          4. Left ventricular ejection fraction (LVEF) ≥25% documented within the last 6 weeks.&#xD;
&#xD;
          5. Acceptable candidate for coronary artery bypass graft surgery (CABG).&#xD;
&#xD;
          6. Patient understands the study requirements and the treatment procedures and provides&#xD;
             written Informed Consent using a form that has been approved by the local&#xD;
             Institutional Review Board or Ethics Committee before any study-specific tests or&#xD;
             procedures are performed.&#xD;
&#xD;
          7. Willing to comply with all specified follow-up evaluations.&#xD;
&#xD;
        Inclusion Criteria (Angiographic):&#xD;
&#xD;
          1. A single de novo lesion per study subject may be treated with the study device.&#xD;
&#xD;
          2. Each target lesion may be composed of multiple lesions but must be completely&#xD;
             coverable by one (1) study stent.&#xD;
&#xD;
          3. Cumulative target lesion length per vessel is ≤24 mm based on a visual estimate.&#xD;
&#xD;
          4. RVD of ≥2.5 mm to ≤3.0 mm based on a visual estimate.&#xD;
&#xD;
          5. Target lesion diameter stenosis ≥50% and &lt;100% based on a visual estimate.&#xD;
&#xD;
          6. Target vessel has not undergone prior revascularization within the preceding 6 months.&#xD;
&#xD;
          7. Target lesion must be a minimum of 10 mm distance from any previously treated segment&#xD;
             of the target vessel&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known sensitivity to cobalt chromium, paclitaxel or polymeric matrices: PLGA.&#xD;
&#xD;
          2. Planned treatment with any other PCI device in the target vessel(s).&#xD;
&#xD;
          3. Acute MI within 72 hours prior to the index procedure as defined by the presence of a&#xD;
             new pathologic Q wave, or creatinine kinase (CK) &gt;2 times the laboratory upper limits&#xD;
             of normal and elevated MB.&#xD;
&#xD;
          4. The patient is in cardiogenic shock.&#xD;
&#xD;
          5. Cerebrovascular Accident (CVA) within the past 6 months.&#xD;
&#xD;
          6. Acute or chronic renal dysfunction (creatinine &gt;2.0 mg/dl or &gt;150 µmol/L).&#xD;
&#xD;
          7. Contraindication to ASA or to clopidogrel.&#xD;
&#xD;
          8. Thrombocytopenia (platelet count &lt;100, 000/mm3).&#xD;
&#xD;
          9. Active gastrointestinal (GI) bleeding within the past three months.&#xD;
&#xD;
         10. Any prior true anaphylactic reaction to contrast agents.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Herz-Kreislauf-Zentrum</name>
      <address>
        <city>Am Kurpark 1</city>
        <state>Segeberger Kliniken GmbH</state>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <study_first_submitted>October 9, 2009</study_first_submitted>
  <study_first_submitted_qc>October 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2009</study_first_posted>
  <last_update_submitted>October 27, 2009</last_update_submitted>
  <last_update_submitted_qc>October 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Sid Cohen, M.D.</name_title>
    <organization>Cordis</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

